Ketanov
Ketanov is a non-steroidal anti-inflammatory drug (NSAID) with potent analgesic properties. It works by inhibiting prostaglandin synthesis to reduce pain and inflammation. It is indicated for the short-term (up to 5 days) management of acute moderate to severe pain, typically after surgery.
Dosage by Body Weight
Adults: Usually 10 mg orally every 4 to 6 hours as needed. Maximum daily dose should not exceed 40 mg. Total duration of use (injection and tablets combined) must not exceed 5 days. Not recommended for pediatric use under 16 years of age for outpatient oral therapy.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy not established in infants.
- Body Weight
- 5-7 kg
- Dose
- Contraindicated
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy not established in this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Oral Ketanov is not recommended for pediatric use in this range.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Oral Ketanov is not recommended for pediatric use in this range.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Oral Ketanov is not routinely used. Seek specialist pediatric guidance if IV formulation is considered in a hospital setting (typically 0.5 mg/kg).
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated | Do not administer | Safety and efficacy not established in infants. |
| 5-7 kg | Contraindicated | Do not administer | Safety and efficacy not established in this weight range. |
| 8-10 kg | Not recommended | Do not administer | Oral Ketanov is not recommended for pediatric use in this range. |
| 11-15 kg | Not recommended | Do not administer | Oral Ketanov is not recommended for pediatric use in this range. |
| 16-20 kg | Not recommended | Do not administer | Oral Ketanov is not routinely used. Seek specialist pediatric guidance if IV formulation is considered in a hospital setting (typically 0.5 mg/kg). |
Formulation
Purpose
Short-term management of moderate to severe acute post-operative pain.
Generic Name
Ketorolac TromethamineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.